SEC Form 4 · accession 0001179110-15-009084
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregg H Alton
Officer — EVP, Corp & Med Affairs
Period of report
Jun 1, 2015
Accepted (ET)
Jun 3, 2015 · 6:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2015 | M | 4,375 | $23.60 | A | 147,797 | D | |
| Common Stock | Jun 1, 2015 | M | 10,625 | $23.755 | A | 158,422 | D | |
| Common StockF3 | Jun 1, 2015 | S | 8,956 | $113.1426 | D | 149,466 | D | |
| Common StockF4 | Jun 1, 2015 | S | 6,044 | $114.3063 | D | 143,422 | D | |
| Common StockF5 | Jun 1, 2015 | S | 1,000 | $113.354 | D | 142,422 | D | |
| Common StockF6 | Jun 1, 2015 | S | 1,000 | $114.3644 | D | 141,422 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $23.60 | Jun 1, 2015 | M | 4,375 | D | — | Jan 21, 2019 | Common Stock | 4,375 | 0 | D |
| Non-Qualified Stock Option (right to buy)F2 | $23.755 | Jun 1, 2015 | M | 10,625 | D | — | Jan 28, 2020 | Common Stock | 10,625 | 31,375 | D |
Explanation of responses
- F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
- F3Sale prices reported for the transactions reported here range from $112.72 to $113.7022. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F4Sale prices reported for the transactions reported here range from $113.73 to $114.71. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F5Sale prices reported for the transactions reported here range from $112.89 to $113.82. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F6Sale prices reported for the transactions reported here range from $114.04 to $114.6484. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.